120 related articles for article (PubMed ID: 436528)
1. Precipitation of heart failure following sudden withdrawal of hydralazine.
Black JR; Mehta J
Chest; 1979 Jun; 75(6):724-5. PubMed ID: 436528
[TBL] [Abstract][Full Text] [Related]
2. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
Pierpont GL; Cohn JN; Franciosa JA
Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
[No Abstract] [Full Text] [Related]
3. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with digoxin and nitroprusside in heart failure complicating acute myocardial infarction.
Raabe DS
Am J Cardiol; 1979 May; 43(5):990-4. PubMed ID: 433783
[No Abstract] [Full Text] [Related]
5. Renal effects of nitroprusside and hydralazine in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Rapaport E
Circulation; 1980 Feb; 61(2):316-23. PubMed ID: 7351056
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA; Pierpont G; Cohn JN
Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
[TBL] [Abstract][Full Text] [Related]
7. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
[No Abstract] [Full Text] [Related]
8. Usefulness of vasodilator therapy in acute and chronic valvular regurgitation.
Greenberg BH; Rahimtoola SH
Curr Probl Cardiol; 1984 Jul; 9(4):1-46. PubMed ID: 6744937
[No Abstract] [Full Text] [Related]
9. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Benowitz NL; Rapaport E
Circulation; 1981 Nov; 64(5):973-6. PubMed ID: 7285311
[TBL] [Abstract][Full Text] [Related]
10. Specific afterload reduction with parenteral hydralazine following cardiac surgery.
Sladen RN; Rosenthal MH
J Thorac Cardiovasc Surg; 1979 Aug; 78(2):195-202. PubMed ID: 459526
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M; Gorlin R
N Engl J Med; 1982 Jan; 306(2):57-62. PubMed ID: 7053487
[TBL] [Abstract][Full Text] [Related]
12. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Laslett LJ; DeMaria AN; Amsterdam EA; Mason DT
Arch Intern Med; 1978 May; 138(5):819-20. PubMed ID: 646547
[TBL] [Abstract][Full Text] [Related]
13. Hydralazine in chronic CHF.
Chatterjee K; Rouleau JL; Massie BM
Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
[TBL] [Abstract][Full Text] [Related]
14. Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathy.
Packer M; Meller J; Medina N; Yushak M; Gorlin R
Am J Cardiol; 1981 Nov; 48(5):939-46. PubMed ID: 7304442
[TBL] [Abstract][Full Text] [Related]
15. [Long-term effects of digoxin and hydralazine in patients with chronic cardiac insufficiency].
Corbalán R; Arriagada D; Rodríguez JA; Chamorro G; Meleda I; Casanegra P; Valenzuela P
Rev Med Chil; 1985 Oct; 113(10):947-53. PubMed ID: 3837287
[No Abstract] [Full Text] [Related]
16. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
Haitas B; Meyer TE; Angel ME; Reef E
Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Greenberg BH; Massie BM
Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
[No Abstract] [Full Text] [Related]
18. Hydralazine in the management of left ventricular failure.
Fitchett DH; Neto JA; Oakley CM; Goodwin JF
Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
[No Abstract] [Full Text] [Related]
19. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
20. Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
Miller RR; Awan NA; Mason DT
Adv Cardiol; 1978; 23():173-81. PubMed ID: 345758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
